Ride your way. 🚴 Choose your route, your distance, and your day or join riders worldwide on August 15 for #Ride2EndALZ Classic. Every dollar raised and every mile pedaled fuels discoveries for Alzheimer’s and all other dementia. Register today at alz.org/rideclassic.

This week, more than 13,000 of the brightest minds in dementia science came together for #AAIC26. 🔬 Together, they’re shaping the future of dementia science and clinical care. We leave inspired and energized by the momentum driving Alzheimer’s and dementia research forward. 💜

Missed all the breaking news from #AAIC26? Here’s a wrap-up of the biggest stories in dementia research. 🧵

@rebeccahenrys114.bsky.social thank you for your @lbc.co.uk coverage of the LatAM-FINGERS study presented at #AAIC26 that demonstrates that an evidence-based lifestyle program improves brain health among older adults at risk for dementia. www.lbc.co.uk/article/exer...

Research from #AAIC26 shows progress across Alzheimer's—from promising tau research and blood tests to risk reduction. As Dr. Maria Carrillo said, "We're beginning to prepare for what that future is going to look like, and it's exciting." Via @TIME: bit.ly/4wDxLdg.

#AAICForAll is happening now! 📣 Join us online for this no-cost, virtual event and learn directly from global experts about the latest discoveries and updates from #AAIC26, and what they mean for patients, caregivers and families: alz.org/aaic-for-all.

Read highlights of the scientific advances reported this week at #AAIC26. https://bit.ly/4aXsaWL

During #AAIC26, one of London’s most iconic landmarks, The London Eye 🎡, glowed purple to help raise awareness of Alzheimer’s and all other dementia while celebrating the global scientific community working to advance research. #ENDALZ

@dmthompsonjr.bsky.social thank you for covering research presented at #AAIC26 that examined the effects of repeated head impacts on brain health in soccer players. www.healthday.com/health-news/...

Join us tomorrow, July 16 at #AAICForAll in London, UK! Register for this no-cost, single-day event to get updates & insights from the world’s largest meeting on dementia science. Learn more: alz.org/aaic-for-all

Research reported at #AAIC26 points to the future of Alzheimer’s care. 🧭 A large, real-world study suggests a blood test may one day help doctors predict a person's risk of developing Alzheimer's up to 10 years before memory or thinking problems appear. bit.ly/4bMz7u3.

#AAIC26 has given us another amazing week of sharing insights, celebrating scientific breakthroughs, & best of all, connecting & reconnecting with friends from around the world. See you next year in Chicago, IL, USA, for #AAIC27 as we continue to move dementia science & clinical practice forward!

"We will be courageous together." We're deeply grateful to Captain Chesley "Sully" Sullenberger and his family for publicly sharing his Alzheimer's diagnosis and their story with such honesty and hope. #ENDALZ If you're facing Alzheimer’s, know that resources are available for you.💜 bit.ly/4gDWVnf

It's the final day of #AAIC26. Throughout the week, attendees: 🤝 Re-connected with their peers and made new connections 💡 Attended thought-provoking scientific sessions 🔬 Shared novel ideas to move the dementia research field forward. Thank you to all the bright minds who joined us! #ENDALZ

#AAIC26 attendees, join us today for the final ASK! sessions beginning at 3:40 p.m. in the ICC Maritime Hall: Stage 1: Q&A session with The Editors Of The Alzheimer’s And Dementia Family Of Journals Stage 2: Q&A session with Plenary Speakers Dag Aarsland, M.D. and Zahinoor Ismail, M.D.

🩸🔮🧭 An Alzheimer’s blood test may help estimate future risk and timing of memory and thinking problems, and help guide health decisions as new treatments emerge. While more research is needed, these findings offer new promise for future Alzheimer’s care. #AAIC26

🏆Dag Aarsland, M.D., is this year’s recipient of the Inge Grundke-Iqbal Award for Alzheimer’s Research. As director of the Centre for Healthy Brain Aging at King’s College London, his research focuses on aging neuropsychiatry and neurodegenerative disorders.

Today’s final #AAIC26 plenary session will start at 11 a.m. BST in Hall S8. Attendees, don’t miss your chance to hear from: 🟣 Dag Aarsland, M.D., King's College London, United Kingdom 🟣 Zahinoor Ismail, M.D., University of Calgary, Canada

An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau.

Rise and grind, #AAIC26 attendees! 🌞☕️

New from #AAIC26: A blood test may help predict risk of cognitive decline due to Alzheimer’s a decade before symptoms appear. Learn More: https://bit.ly/3ThnRiY

Research presented at #AAIC26 points to a future where a highly accurate Alzheimer’s diagnosis may begin in your primary care office.

It's almost time for today's #AAIC26 ASK! Sessions at 3:40 p.m. in the ICC Maritime Hall - visit Stage 1 for a Q&A Session with AAIC Award Winners, or hear from plenary speakers Takaomi C. Saido, Ph.D. and Betty Tijms, Ph.D. on Stage 2.

Today at #AAIC26: Join a guided conversation at 3:30 p.m. BST in Connaught 2/3/4 on select posters, hosted by the people behind the research. Explore the work alongside the author, ask questions, and hear more about their insights.

Attending #AAIC26? Be sure to look up tonight. The London Eye will shine purple to celebrate the Alzheimer's Association International Conference & raise Alzheimer's awareness. Thanks to the London Convention Bureau for welcoming the global research community in such a special way.

#AAIC26 attendees: Head to our booth (601) on Wed 7/15 from 10:30–11:00 a.m. to meet Gil D. Rabinovici, M.D., part of the leadership team behind ALZ-NET, a longitudinal patient registry designed to collect real-world clinical data on those receiving FDA-approved Alzheimer's treatments.

Research reported today at #AAIC26 showed a new experimental approach combining THC and CBD significantly reduced agitation in people with late-stage Alzheimer’s and other dementias who were eligible to receive hospice care. Benefits were seen in two weeks. Learn more: nyti.ms/4vysZNl.

#AAIC26 attendees: Want more info on ALZPro? Visit our team at Booth 601 in the Exhibit Hall to discover how our professional hub offers essential resources, and follow @alzpro.bsky.social#AAIC26for future updates.

#AAIC26 Attendees: Our Tuesday plenary session begins at 11 a.m. in Hall 58. Don't miss our next set of expert keynotes from: 🟣 Takaomi C. Saido, Ph.D., from RIKEN Center for Brain Science, Japan 🟣 Betty Tijms, Ph.D., from Amsterdam UMC, Netherlands

We’ve had an incredible few days, and #AAIC26 attendees are still going strong! Keep it up and add a Zen Den chair massage 💺 to your itinerary today, available now from 9 a.m. – 4 p.m. BST in Greenwich 3/4.

Just in from #AAIC26: Topline results from LiBBY Trial show THC/CBD combination significantly reduces agitation for people with dementia at end of life. Learn More: https://bit.ly/4yjnAMD

📰 Research News: Alzheimer’s blood test could bring highly accurate diagnosis into everyday clinical care, according to a study reported at #AAIC26. Learn More: https://bit.ly/3T3trW8

Health care professionals: #AAICForAll is your chance to hear about the latest research designed to improve clinical outcomes and equip you with the tools to provide higher-quality care. Participate virtually or in-person on your own schedule: https://bit.ly/AAICClinicians.

Lucia Crivelli presenting evidence that a culturally adapted multidimensional lifestyle intervention can help reduce cognitive decline in Spanish speaking older adults (LatAm FINGERS study). #AAIC26 @alzassociation.bsky.social

#AAIC26 attendees: Head to our ASK! Sessions in the ICC Maritime Hall starting at 3:40 p.m. On Stage 1, speaker Ryan Watts, Ph.D., will host a Q&A on his Monday plenary.

Join a guided conversation on select posters, hosted by the people behind the research! Explore their work alongside the authors, ask questions, and hear more about their insights starting at 3:30 p.m. BST in Connaught 2/3/4.

#AAIC26 attendees: Miss the first of today’s guided meditations in the Zen Den? You’ve still got two more chances! Head to Greenwich 3/4 at 2 p.m. or 4 p.m. BST for a calming moment of peace among the joyful conference chaos.

#AAIC26 attendees: Meet the leadership team behind ALZ-NET, a longitudinal patient registry designed to collect real-world clinical data on those receiving FDA-approved Alzheimer's treatments. Monday, 12:30-1:40 p.m. Michael S. Rafii, MD, Ph.D. Wednesday, 10:30–11:00 a.m. Gil D. Rabinovici, M.D.

News from #AAIC26: Results from the Alzheimer's Association-funded LatAm-FINGERS study build on last year’s landmark findings from U.S. POINTER.

🏆 Ganesh Babulal, Ph.D., OTD, MSCI, MOT, OTR/L, is the recipient of the 2026 Bill Thies Award for Distinguished Service to ISTAART, an award that recognizes an @istaart.bsky.social member who has provided continued and outstanding service to the community.

Our @mariacarrilloalz.bsky.social shares some exciting #AAIC26 stats: 🔬 Over 10,200 attendees are here in London and nearly 3,000 are joining us online 🔬 Attendees from 115 countries 🔬 52% attendees are women 🔬 35% of attendees are under age 35 🔬 More than 41% are first-time attendees

#AAIC26 attendees, don’t miss this morning’s plenary session at 11 a.m. BST in Hall 58, featuring 🟣@suzanneeschindler.bsky.social#AAIC26M.D., Ph.D., Washington University School of Medicine, United States 🟣Daisy Acosta, M.D., Universidad Nacional Pedro Henriquez Urena (UNPHU), Dominican Republic

It's Day 2 of #AAIC26! Explore today's sessions, networking opportunities and events at alz.org/aaic.

📰 Today the Association announced the launch of the PROTECT-Cog Study to test U.S. POINTER lifestyle and GLP-1 or similar drug to cut risk of cognitive decline. Learn More: https://bit.ly/4pekZiJ

📰 Breaking news from #AAIC26: Lifestyle program improves brain health among older adults at risk for dementia across Latin America — confirming and expanding Alzheimer’s Association-funded U.S. POINTER Trial results. Learn More: https://bit.ly/4f7dJ3z

#AAIC26 attendees, make your way to N9 for our welcome reception and a stroll through London! 💂 Connect and reconnect with colleagues as the city comes to life with local flavors and experiences. The beats and bites begin now. We can’t wait to see you here!

#AAIC26 attendees: Don’t miss today’s ASK! Session with our president and CEO Dr. Joanne Pike & our Chief Science Officer @mariacarrilloalz.bsky.social#AAIC26at 3:40 p.m. BST on Stage 2 in the ICC Maritime Hall.

New research presented at #AAIC26 is helping us better understand how repetitive head impacts may affect brain health over time. Read more from the BBC: www.bbc.co.uk/sport/footba...

We are honored to present Debbie and Clay Jones with the Jerome H. Stone Philanthropy Award for Alzheimer’s Research at #AAIC26. Their leadership, vision and transformative impact are advancing progress in Alzheimer’s science. aaic.alz.org/releases-202...

🏆 Adesola Ogunniyi, M.D., is the 2026 recipient of the Bengt Winblad Lifetime Achievement Award in Alzheimer’s Disease Research. Dr. Ogunniyi is an Emeritus Professor of Medicine at the University of Ibadan, Nigeria.